| scholarly article | Q13442814 |
| P2093 | author name string | Miller P | |
| Abrams PG | |||
| Foon KA | |||
| Larson SM | |||
| Stevenson HC | |||
| Ottow RT | |||
| Woodhouse C | |||
| Keenan AM | |||
| Steller EP | |||
| Beman J | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 6100-6103 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis | |
| P478 | volume | 47 |
| Q56517336 | A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron (Peginterferon alfa-2b) and Actimmune (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer |
| Q41504612 | Activated monocytes kill malignant brain tumor cells in vitro |
| Q38015061 | Biological response modifiers in the management of patients with breast cancer |
| Q54206413 | In vitro purging of clonogenic leukaemic cells from human bone marrow by interferon-gamma-activated monocytes. |
| Q38898549 | Macrophage-based cell therapies: The long and winding road |
| Q35973378 | Monocyte and interferon based therapy for the treatment of ovarian cancer |
| Q35992797 | Multiple epitopes of the human ovarian cancer antigen 14C1 recognised by human IgG antibodies: their potential in immunotherapy |
| Q64094101 | Production of a cellular product consisting of monocytes stimulated with Sylatron (Peginterferon alfa-2b) and Actimmune (Interferon gamma-1b) for human use |
| Q41646200 | Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line |
| Q90436683 | Type I IFN, Ly6C+ cells, and phagocytes support suppression of peritoneal carcinomatosis elicited by a TLR and CLR agonist combination |
Search more.